Efficient synthesis method of 3, 4, 6-triaryl substituted pyridazine compound
Through copper-promoted C(sp3)-C(sp3) bond coupling and ring-forming reaction, 3,4,6-triaryl-substituted pyridazine compounds were prepared directly from acylhydrazone and phenylbenzylketone in one step, and the current solution was solved There are problems of poor economicality and waste generation in the technology, and efficient and green pyridazine compound synthesis has been achieved, with excellent step economy and chemical selectivity.
Patent Information
- Application Number
- CN202410976035.2
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-07-19
- Publication Date
- 2024-11-08
AI Technical Summary
The existing pyridazine compounds synthesis methods rely on β, γ-unsaturated hydrazones and α-halogenated hydrazones, resulting in poor economic efficiency and waste generation, making it difficult to meet the requirements of green chemistry and sustainable development.
Using copper-promoted C(sp3)-C(sp3) bond coupling and ring formation reaction, the 3,4,6-triaryl-substituted pyridine was directly prepared by using simple acylhydrazone and phenylbenzylketone as the reaction substrate. The azine compound avoids the prefunctionalization of acylhydrazone substrates and the emission of hydrogen halide.
It has achieved efficient, economical and green synthesis of 3,4,6-triaryl-substituted pyridazine compounds, with excellent step economy and atomic economy, easy operation, good chemical selectivity, wide range of adaptation, strong functional group compatibility .
Smart Images

Figure QLYQS_1 
Figure QLYQS_2 
Figure QLYQS_3
Abstract
Description
Technical Field
[0001] The invention belongs to the field of organic synthesis, and specifically relates to a high-efficiency synthesis method of a 3,4,6-triaryl substituted pyridazine compound. Background Art
[0002] Pyridazines are a class of six-membered nitrogen-containing heterocyclic rings that are widely found in natural products, drugs, bioactive molecules, and functional materials. In addition, pyridazines are important building blocks for organic synthesis and can be used as ligands to synthesize high value-added metal organic complexes. Given the importance and wide range of uses of the pyridazine skeleton, developing green and efficient methods for synthesizing the pyridazine skeleton (especially polysubstituted pyridazines) has always been a research hotspot in organic synthetic chemistry.
[0003] Hydrazones are a class of widely used intermediates in organic synthesis. In recent years, hydrazone compounds have become one of the most attractive synthetic strategies for constructing nitrogen-containing heterocyclic skeletons due to their variable structures and the presence of nitrogen atoms. However, the transformations reported so far rely on β,γ-unsaturated hydrazones and α-halogenated hydrazones as reaction substrates, resulting in poor step economy and the generation of a large amount of waste. Therefore, in order to better meet the requirements of green chemistry and sustainable development, it is of great research value and practical significance to develop new economical and efficient methods for the synthesis of polysubstituted pyridazine skeletons. Summary of the invention
[0004] The present invention provides an economical and efficient method for synthesizing 3,4,6-triaryl substituted pyridazine compounds. The synthesis method directly uses simple acylhydrazone as a reaction substrate and reacts with C(sp 3 )-C(sp 3 ) bond coupling and annulation reaction in one step to prepare 3,4,6-triaryl substituted pyridazines, which has the advantages of a wide substrate applicability, functional group compatibility and excellent chemical selectivity, and exhibits excellent step economy and atom economy.
[0005] A method for synthesizing a 3,4,6-triaryl substituted pyridazine compound comprises the following steps: adding an N-benzoyl substituted acylhydrazone compound, a phenylbenzyl ketone compound, a catalyst, an oxidant and an acid additive into an organic solvent, reacting for 9 to 15 hours at a temperature controlled at 90 to 110° C. under a nitrogen atmosphere, and after the reaction is complete, post-treating to obtain the corresponding 3,4,6-triaryl substituted pyridazine compound;
[0006] The structure of the N-benzoyl-substituted acylhydrazone compound is shown in formula (II):
[0007]
[0008] The structure of the phenyl benzyl ketone compound is shown in formula (III):
[0009]
[0010] The structure of the 3,4,6-triaryl substituted pyridazine compound is shown in formula (I):
[0011]
[0012] In formulas (I) to (III), R 1 is selected from H, C1-C4 alkyl, phenoxy, halogen, C1-C4 alkoxy or R 1 Connect with R 1 The benzene rings together form a naphthyl group;
[0013] R 2 is selected from H, halogen, C1-C4 alkyl or R 2 Connect with R 2 The benzene rings together form a naphthyl group;
[0014] R 3 Selected from H, halogen or C1-C4 alkyl;
[0015] In the present invention, acylhydrazone and phenylbenzyl ketone, which are widely available and easy to synthesize, are directly used as reaction substrates, and C(sp 3 )-C(sp 3 ) bond coupling and subsequent tandem cyclization reaction can efficiently prepare 3,4,6-triaryl substituted pyridazine compounds in one step.
[0016] Preferably, the R 1 is selected from H, methyl, phenoxy, fluorine, bromine, methoxy or R 1 Connect with R 1 The benzene rings together form a naphthyl group;
[0017] The R 2 is selected from H, chlorine, bromine, tert-butyl, methyl or R 1 Connect with R 1 The benzene rings together form a naphthyl group;
[0018] The R 3 Selected from H, fluoro or methyl.
[0019] Preferably, the catalyst is copper acetate.
[0020] Preferably, the oxidant is 2,2,6,6-tetramethylpiperidinyloxy compound.
[0021] Preferably, the acid additive is acetic acid.
[0022] Preferably, the organic solvent is acetonitrile.
[0023] Preferably, the molar ratio of the N-benzoyl-substituted acylhydrazone compound to the phenylbenzyl ketone compound is 1-1.5:1.
[0024] Preferably, the reaction gas atmosphere is under a nitrogen atmosphere.
[0025] Preferably, the reaction temperature is 100° C. and the reaction time is 12 hours.
[0026] Compared with the prior art, the beneficial effects of the present invention are as follows:
[0027] (1) The present invention directly starts from the inert carbon-hydrogen bond, which can effectively avoid the pre-functionalization of the acylhydrazone substrate and the emission of hydrogen halide, and can efficiently realize the synthesis of 3,4,6-triaryl substituted pyridazine compounds in one step, with excellent step economy and green economy.
[0028] (2) The synthetic method of the present invention is easy to operate, exhibits excellent chemical selectivity, has a wide substrate adaptability range, and has good functional group compatibility. BRIEF DESCRIPTION OF THE DRAWINGS
[0029] Figure 1 The hydrogen and carbon spectra of the compound obtained in Example 1;
[0030] Figure 2 The hydrogen and carbon spectra of the compound obtained in Example 2;
[0031] Figure 3 The hydrogen and carbon spectra of the compound obtained in Example 3;
[0032] Figure 4 The hydrogen and carbon spectra of the compound obtained in Example 4;
[0033] Figure 5 The hydrogen and carbon spectra of the compound obtained in Example 5;
[0034] Figure 6 The hydrogen and carbon spectra of the compound obtained in Example 6;
[0035] Figure 7 The hydrogen and carbon spectra of the compound obtained in Example 7;
[0036] Figure 8 The hydrogen and carbon spectra of the compound obtained in Example 8;
[0037] Fig. 9 The hydrogen and carbon spectra of the compound obtained in Example 9;
[0038] Fig.10The hydrogen and carbon spectra of the compound obtained in Example 10;
[0039] Fig.11 The hydrogen and carbon spectra of the compound obtained in Example 11;
[0040] Fig.12 The hydrogen and carbon spectra of the compound obtained in Example 12;
[0041] Fig.13 The hydrogen and carbon spectra of the compound obtained in Example 13;
[0042] Fig.14 The hydrogen and carbon spectra of the compound obtained in Example 14;
[0043] Fig.15 The hydrogen and carbon spectra of the compound obtained in Example 15;
[0044] The hydrogen spectrum was tested on a 400MHz or 500MHz nuclear magnetic resonance instrument. The carbon spectrum was tested on a 125MHz or 100MHz nuclear magnetic resonance instrument. The test conditions were all room temperature with tetramethylsilane as the internal standard and the sample was dissolved in deuterated chloroform. DETAILED DESCRIPTION
[0045] The present invention is further described below in conjunction with specific embodiments, and the following specific embodiments are all optimal implementation modes of the present invention.
[0046] Examples 1 to 15
[0047] According to the raw material ratio in Table 1, N-benzoyl substituted acylhydrazone compound (II, 0.3mmol), phenylbenzyl ketone (III, 0.2mmol), acetic acid ketone (0.2mmol), TEMPO (0.4mmol), acetic acid (0.32mmol) and organic solvent acetonitrile (2mL) were added to a 25mL sealed tube, mixed and stirred evenly, and reacted in an oil bath (100°C) under a nitrogen atmosphere for 12h. After the reaction was completed according to the reaction conditions in Table 2, the reaction was cooled, the organic phase was extracted and collected, dried with sodium sulfate, mixed with silica gel, and purified by column chromatography to obtain the corresponding 3,4,6-triaryl substituted pyridazine compound (I). The reaction process is shown in the following formula:
[0048]
[0049] Table 1 Raw material ratios of Examples 1 to 15
[0050]
[0051]
[0052] aR 1 or R 2 Together with the benzene ring it forms a naphthyl group.
[0053] Table 2 Reaction conditions and reaction results of Examples 1 to 15
[0054]
[0055] In Table 1 and Table 2, T is the reaction temperature, and t is the reaction time.
[0056] The structural confirmation data of the 3,4,6-trisubstituted pyridazine compounds prepared in Examples 1 to 15 are as follows:
[0057] 3,4,6-triphenylpyridazine (I-1): yellow solid (55.4 mg, 90%). mp: 165-166°C. Purified by silica gel column chromatography (eluent: petroleum ether / ethyl acetate, 15 / 1). 1 H NMR (500MHz, CDCl3) δ8.20 (d, J = 7.5Hz, 2H), 7.86 (s, 1H), 7.57-7.50 (m, 5H), 7.37-7.30 (m, 6H), 7.28-7.26 (m, 2H). 13 C NMR (125MHz, CDCl3) δ158.2,157.8,139.5,137.2,136.7,136.2,130.1,129.1,129.1,128.8,128.7,128.1,127.1,124.8.HRMS(ESI-TOF)m / z:[M+H] + Calcd for C 22 H 17 N2 309.1386,Found309.1374.
[0058]
[0059] 3,4-diphenyl-6-(p-tolyl)pyridazine(I-2): yellow solid (53.5 mg, 83%). mp: 196-197°C. Purified by silica gel column chromatography (eluent: petroleum ether / ethyl acetate, 15 / 1). 1 H NMR (400MHz, CDCl3) δ8.15(d,J=7.5Hz,2H),7.87(s,1H),7.55(d,J=7.5Hz,2H),7.42-7.30(m,10H),2.49(s,3H). 13CNMR (125MHz, CDCl3) δ158.3,157.7,139.5,138.8,136.9,136.2,134.2,130.0,130. 0,129.5,129.0,129.0,128.7,128.1,127.1,124.8,21.3.HRMS(ESI-TOF)m / z:[M+H] + Calcdfor C 23 H 19 N2 323.1543,Found 323.1545.
[0060]
[0061] 6-(4-phhenoxyphenyl)-3,4-diphenylpyridazine (I-3): yellow solid (66.4 mg, 83%). mp: 165-166°C. Purified by silica gel column chromatography (eluent: petroleum ether / ethyl acetate, 15 / 1). 1 H NMR (400MHz, CDCl3) δ8.26(d,J=8.4Hz,2H),7.88(s,1H),7.57(d,J=7.2Hz,2H),7.48-7.33(m,10H),7.24-7.17(m,5H). 13 C NMR (100MHz, CDCl3) δ159.5,156.5,137.3,136.8,130.9,130.1,130.0,129.2,12 8.8,128.8,128.7,128.2,124.4,124.0,119.6,118.8.HRMS(ESI-TOF)m / z:[M+Na] + Calcd for C 28 H 21 N2O 423.1468,Found 423.1451.
[0062]
[0063] 6-(4-fluorophenyl)-3,4-diphenylpyridazine (I-4): yellow solid (54.1 mg, 83%). mp: 174-175°C. Purified by silica gel column chromatography (eluent: petroleum ether / ethyl acetate, 15 / 1). 1H NMR (400MHz, CDCl3) δ8.10-8.06(m,2H),7.70(s,1H),7.39(d,J=7.2Hz,2H),7.26-7.19(m,6H),7.16-7.13(m,3H),7.11-7.09(m,1H). 13 C NMR(125MHz,CDCl3)δ164.2(d,J C-F =248.8Hz),158.2,156.8,139.6,137.1,136.6,132.3(d,J C-F =3.8Hz),130.0,129.1,129.0,129.0,128.8,128.8,128.2,124.5,116.1(d,J C-F =22.5Hz).HRMS(ESI-TOF)m / z:[M+H] + Calcd for C 22 H 16 FN2327.1292,Found 327.1321.
[0064]
[0065] 6-(3-fluorophenyl)-3,4-diphenylpyridazine (I-5): yellow solid (51.5 mg, 79%). mp: 202-203°C. Purified by silica gel column chromatography (eluent: petroleum ether / ethyl acetate, 15 / 1). 1 HNMR(500MHz, CDCl3)δ7.87-7.84(m,2H),7.73(s,1H),7.41-7.38(m,3H),7.27 -7.24(m,4H),7.23-7.21(m,2H),7.17(d,J=7.0Hz,2H),7.10(t,J=9.0Hz,1H). 13 C NMR(125MHz,CDCl3)δ163.4(d,J C-F =243.8Hz),158.7,156.5,139.6,138.4(d,J C-F =7.5Hz),137.0,136.6,130.6(d,J C-F =7.5Hz),130.1,129.1,128.9,128.9,128.8,128.2,124.9,122.6(d,J C-F =2.5Hz),117.0(d,J C-F =21.3Hz),114.1(d,JC-F =23.8Hz).HRMS(ESI-TOF)m / z:[M+H] + Calcd for C 22 H 16 FN2327.1292,Found 327.1313.
[0066]
[0067] 6-(3-bromophenyl)-3,4-diphenylpyridazine (I-6): yellow solid (57.3 mg, 74%). mp: 140-141°C. Purified by silica gel column chromatography (eluent: petroleum ether / ethyl acetate, 15 / 1). 1 H NMR (400MHz, CDCl3) δ8.26 (s, 1H), 8.04 (d, J = 7.6Hz, 1H), 7.73 (s, 1H), 7.54 (d, J = 8.0Hz, 1H),7.41(d,J=8.0Hz,2H),7.34-7.30(m,1H),7.30-7.22(m,6H),7.17(d,J=3.6Hz,2H). 13 C NMR(125MHz, CDCl3)δ138.2,133.0,130.6,130.1,130.0,129.1,128.9,128.9,128.8,128.2,125.6,123.3.HRMS(ESI-TOF)m / z:[M+H] + Calcd for C 22 H 16 BrN2 387.0491,Found 387.0475.
[0068]
[0069] 6-(3-methoxyphenyl)-3,4-diphenylpyridazine (I-7): yellow solid (54.8 mg, 81%). mp: 107-108°C. Purified by silica gel column chromatography (eluent: petroleum ether / ethyl acetate, 15 / 1). 1 H NMR (400MHz, CDCl3) δ7.77(d,J=12.0Hz,2H),7.59(d,J=7.6Hz,1H),7.42(d,J=7.6H z,2H),7.34(t,J=8.0Hz,1H),7.28-7.17(m,8H),6.97(d,J=8.4Hz,1H),3.82(s,3H). 13C NMR (100MHz, CDCl3) δ160.3,139.5,137.5,137.2,136.8,130.1,130.1,129. 1,128.8,128.2,125.0,119.4,116.5,112.0,55.5.HRMS(ESI-TOF)m / z:[M+H] + Calcd for C 23 H 19 N2O 339.1492,Found 339.1509.
[0070]
[0071] 6-(naphthalen-2-yl)-3,4-diphenylpyridazine (I-8): yellow solid (59.4 mg, 83%). mp: 173-174°C. Purified by silica gel column chromatography (eluent: petroleum ether / ethyl acetate, 15 / 1). 1 H NMR (400MHz, CDCl3) δ8.67(s,1H),8.37(d,J=8.4Hz,1H),8.03-7.97(m,3H),7.91(d,J=4.4Hz,1H),7.56-7.53(m,4H),7.40-7.29(m,8H). 13 CNMR (125MHz, CDCl3) δ158.2,157.6,139.5,137.3,136.8,134.2,133.4,130.1,129.1,128.9,128. 9,128.8,128.8,128.8,128.2,127.8,127.1,126.9,126.6,125.0,124.3.HRMS(ESI-TOF)m / z:[M+H] + Calcd for C 26 H 19 N2359.1543,Found 359.1532.
[0072]
[0073] 3-(4-chlorophenyl)-4,6-diphenylpyridazine (I-9): yellow solid (50.7 mg, 74%). mp: 138-139°C. Purified by silica gel column chromatography (eluent: petroleum ether / ethyl acetate, 15 / 1). 1H NMR (400MHz, CDCl3) δ8.08 (d, J = 7.2Hz, 2H), 7.74 (s, 1H), 7.46-7.37 (m, 5H), 7.31-7.26 (m, 3H), 7.18-7.15 (m, 2H), 6.92-6.88 (m, 2H). 13 C NMR (125MHz, CDCl3) δ164.2,162.2,137.1,136.0,132.8,132.0,131.9,130.1,12 9.1,129.0,128.9,128.9,127.1,124.9,115.4,115.2.HRMS(ESI-TOF)m / z:[M+H] + Calcd for C 22 H 16 ClN2 343.0997,Found 343.0997.
[0074]
[0075] 3-(4-fluorophenyl)-4,6-diphenylpyridazine (I-10): yellow solid (55.7 mg, 72%). mp: 160-161°C. Purified by silica gel column chromatography (eluent: petroleum ether / ethyl acetate, 15 / 1). 1 H NMR (400MHz, CDCl3) δ8.27(d,J=7.2Hz,2H),7.93(s,1H),7.65-7.59(m,3H),7.54(d,J=8.0Hz,2H),7.48-7.46(m,3H),7.38-7.34(m,4H). 13 CNMR (125MHz, CDCl3) δ157.9,157.1,139.4,136.9,136.0,135.2,135.1,131.4,1 30.2,129.1,129.0,129.0,129.0,128.4,127.1,124.9.HRMS(ESI-TOF)m / z:[M+H] + Calcd for C 22 H 16 BrN2 387.0491,Found 387.0493.
[0076]
[0077] 3-(4-(tert-butyl)phenyl)-4,6-diphenylpyridazine(I-11): yellow solid (42.2 mg, 58%). mp: 122-123°C. Purified by silica gel column chromatography (eluent: petroleum ether / ethyl acetate, 15 / 1). 1 H NMR (400MHz, CDCl3) δ8.09(d,J=6.8Hz,2H),7.72(s,1H),7.45-7.39(m,3H),7.35(d,J=8.4Hz,2H),7.28-7.18(m,7H),1.21(s,9H). 13 C NMR (100MHz, CDCl3) δ158.1,157.5,152.0,139.3,137.5,136.3,133.7,130.0,129.8,1 29.1,129.1,128.8,128.7,127.1,125.1,124.9,34.7,31.3.HRMS(ESI-TOF)m / z:[M+Na] + Calcd for C 26 H 24 N2Na 387.1832,Found387.1858.
[0078]
[0079] 4,6-diphenyl-3-(m-tolyl)pyridazine(I-12): yellow solid (39.3 mg, 61%). mp: 117-118°C. Purified by silica gel column chromatography (eluent: petroleum ether / ethyl acetate, 15 / 1). 1 H NMR (400MHz, CDCl3) δ8.10 (d, J=6.0Hz, 2H), 7.75 (s, 1H), 7.48-7.41 (m, 3H), 7.3 6(s,1H),7.28-7.26(m,3H),7.19-7.17(m,2H),7.09-7.05(m,3H),2.22(s,3H). 13 C NMR (125MHz, CDCl3) δ137.9,137.3,136.6,136.2,130.7,130.0,129.5,129.1,1 29.1,128.7,128.7,127.8,127.2,127.1,124.8,21.4.HRMS(ESI-TOF)m / z:[M+H] + Calcd for C 23 H 19N2 323.1543,Found 323.1511.
[0080]
[0081] 3-(naphthalen-2-yl)-4,6-diphenylpyridazine(I-13): yellow solid (59.4 mg, 83%). mp: 153-154°C. Purified by silica gel column chromatography (eluent: petroleum ether / ethyl acetate, 15 / 1). 1 H NMR (400MHz, CDCl3) δ8.10 (d, J=6.8Hz, 2H), 8.05 (s, 1H), 7.76 (s, 1H), 7.69 -7.64(m,2H),7.59(d,J=8.4Hz,1H),7.45-7.33(m,6H),7.24-7.18(m,5H). 13 C NMR (100MHz, CDCl3) δ158.1,157.8,139.7,137.3,136.2,134.3,133.3,133.2,130.1,129.2,129.1 ,128.9,128.8,128.7,127.7,127.6,127.3,127.2,126.8,126.2,124.9.HRMS(ESI-TOF)m / z:[M+H] + Calcd for C 26 H 19 N2 359.1543,Found 359.1532.
[0082]
[0083] 4-(4-fluorophenyl)-3,6-diphenylpyridazine (I-14): yellow solid (29.3 mg, 45%). mp: 175-176°C. Purified by silica gel column chromatography (eluent: petroleum ether / ethyl acetate, 15 / 1). 1 H NMR (400MHz, CDCl3) δ8.17 (d, J = 8.0Hz, 2H), 7.80 (s, 1H), 7.55-7.46 (m, 5H), 7.35-7.29 (m, 3H), 7.25-7.21 (m, 2H), 7.01-7.05 (m, 2H). 13 C NMR(125MHz,CDCl3)δ163.0(d,J C-F =248.8Hz),158.2,157.8,138.5,136.6,136.0,133.2(d,JC-F =2.5Hz),131.0(d,J C-F =7.5Hz),130.2,130.0,129.1,128.9,128.3,127.1,124.7,116.0(d,J C-F =21.3Hz).HRMS(ESI-TOF)m / z:[M+H] + Calcd for C 22 H 16 FN2 327.1292, Found 327.1313.
[0084]
[0085] 3,6-diphenyl-4-(p-tolyl)pyridazine(I-15): yellow solid (47.0 mg, 73%). mp: 128-129°C. Purified by silica gel column chromatography (eluent: petroleum ether / ethyl acetate, 15 / 1). 1 H NMR (400MHz, CDCl3) δ8.18(d,J=8.0Hz,2H),7.83(s,1H),7.56-7.49(m,5H),7.35-7.29(m,3H),7.18-7.12(m,4H),2.36(s,3H). 13 C NMR (125MHz, CDCl3) δ160.3,158.3,157.5,139.5,137.5,137.2,136.7,130.1,130. 0,129.1,128.8,128.1,125.0,119.3,116.5,111.9,55.5.HRMS(ESI-TOF)m / z:[M+H] + Calcd for C 23 H 19 N2 323.1543, Found 323.1555.
Claims
1. A highly efficient method for synthesizing 3,4,6-triaryl substituted pyridazine compounds, It is characterized in that The method comprises the following steps: adding an N-benzoyl-substituted acylhydrazone compound, a phenylbenzyl ketone compound, a catalyst, an oxidant and an acid additive into an organic solvent, controlling the temperature at 90 to 110° C. under nitrogen gas conditions to react for 9 to 15 hours, and after the reaction is complete, post-treating to obtain a corresponding 3,4,6-triaryl-substituted pyridazine compound; The structure of the N-benzoyl-substituted acylhydrazone compound is shown in formula (II): The structure of the phenyl benzyl ketone compound is shown in formula (III): The structure of the 3,4,6-triaryl substituted pyridazine compound is shown in formula (I): In formulas (I) to (III), R 1 Selected from H, C 1 ~C 4 Alkyl, phenoxy, halogen, C 1 ~C 4 Alkoxy or R 1 Connect with R 1 The benzene rings together form a naphthyl group; R 2 Selected from H, halogen, C 1 ~C 4 Alkyl or R 2 Connect with R 2 The benzene rings together form a naphthyl group; R 3 Selected from H, halogen or C 1 ~C 4 alkyl.
2. The synthesis method according to claim 1, It is characterized in that The R 1 is selected from H, methyl, phenoxy, fluorine, bromine, methoxy or R 1 Connect with R 1 The benzene rings together form a naphthyl group; the R 2 is selected from H, chlorine, bromine, tert-butyl, methyl or R 2 Connect with R 2 The benzene rings of 3 Selected from H, fluorine or methyl.
3. The synthesis method according to claim 1, It is characterized in that The organic solvent is acetonitrile.
4. The synthesis method according to claim 1, It is characterized in that The catalyst is acetic acid ketone.
5. The synthesis method according to claim 1, It is characterized in that The oxidant is 2,2,6,6-tetramethylpiperidinyloxy (TEMPO).
6. The synthesis method according to claim 1, It is characterized in that The acid additive is acetic acid.
7. The synthesis method according to claim 1, It is characterized in that The molar ratio of the N-benzoyl substituted acylhydrazone compound to the phenylbenzyl ketone compound is 1.5-1:
1.
8. The synthesis method according to claim 1, It is characterized in that The 3,4,6-triaryl substituted pyridazine compound is one of the following compounds:
